A Follow-up Study in Patients With Inherited Metabolic Disorders (IMD) Who Underwent Hematopoietic Stem Cell Transplantation (HSCT) With MGTA-456

NCT04008849 · clinicaltrials.gov ↗

TERMINATED

Status

3

Enrollment

INDUSTRY

Sponsor class

Stopped Due to low enrollment

Conditions

Inherited Metabolic Disorders (IMD)

Interventions

OTHER: Safety and efficacy assessments

Sponsor

Magenta Therapeutics, Inc.